Patents by Inventor Serguei J. Lejnine

Serguei J. Lejnine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for sepsis
    Patent number: 8029982
    Abstract: Biomarkers for sepsis and resulting mortality can be detected by assaying blood samples. Changes in the concentration of the biomarkers can be used to indicate sepsis, risk of sepsis, progression of sepsis, remission from sepsis, and risk of mortality. Changes can be evaluated relative to data sets, natural or synthetic or semisynthetic control samples, or patient samples collected at different time points. Some biomarkers' concentrations are elevated during disease and some are depressed. These are termed informative biomarkers. Some biomarkers are diagnostic in combination with others. Individual biomarkers may be weighted when used in combinations. Biomarkers can be assessed in individual, isolated or assays, in parallel assays, or in single-pot assays.
    Type: Grant
    Filed: May 6, 2010
    Date of Patent: October 4, 2011
    Assignee: Alere San Diego, Inc.
    Inventors: Stephen F. Kingsmore, Serguei J. Lejnine, Mark Driscoll, Velizar T. Tchernev
  • BIOMARKERS FOR SEPSIS
    Publication number: 20100304981
    Abstract: Biomarkers for sepsis and resulting mortality can be detected by assaying blood samples. Changes in the concentration of the biomarkers can be used to indicate sepsis, risk of sepsis, progression of sepsis, remission from sepsis, and risk of mortality. Changes can be evaluated relative to data sets, natural or synthetic or semisynthetic control samples, or patient samples collected at different time points. Some biomarkers' concentrations are elevated during disease and some are depressed. These are termed informative biomarkers. Some biomarkers are diagnostic in combination with others. Individual biomarkers may be weighted when used in combinations. Biomarkers can be assessed in individual, isolated or assays, in parallel assays, or in single-pot assays.
    Type: Application
    Filed: May 6, 2010
    Publication date: December 2, 2010
    Applicant: BIOSITE INCORPORATED
    Inventors: Stephen F. Kingsmore, Serguei J. Lejnine, Mark Driscoll, Velizar Tchemev